Trinity Biotech plc (TRIB)
$6.61+4.92%Close
SELLCRISIS · day 43
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $7M
- Beta
- 0.97
- P/E (TTM)
- -0.14
- Short % float
- 2.24%
- Days to cover
- 2.1
- SI change
- +123.3%
- 1W
- -2.07%
- 1M
- -9.82%
- vs SPY 1W
- -1.94%
- vs SPY 1M
- -12.33%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 5
- GROWTH
- 16
- GARP
- 2
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC29.2%
REV YoY-
ROE48.7%
EPS YoY-
ROA-27.2%
GROSS38
OP-18
NET-79
[VALUATION]
P/E TTM-0.14
P/E FWD-
SECTOR PE20.48
INDUSTRY PE10.79
P/B-0.06
P/FCF-
EV/EBITDA-59.65
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO0.25
ND/EBITDA-
BETA0.97
Company news
FAQ
- What is LOPJLB’s current signal on TRIB?
- LOPJLB’s latest quantitative signal on Trinity Biotech plc (TRIB) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is TRIB in?
- Trinity Biotech plc (TRIB) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Trinity Biotech plc (TRIB) do?
- Trinity Biotech plc, an Irish enterprise founded in 1992 and headquartered in Bray, is engaged in the acquisition, development, manufacturing, and global distribution of medical diagnostic solutions. The company's reach extends to the Americas, Africa, Asia, and Europe, catering to both clinical laboratory and point-of-care diagnostic markets. Its extensive range of clinical laboratory offering…